About varex imaging corp - VREX
Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded on July 18, 2016 and is headquartered in Salt Lake City, UT.
VREX At a Glance
Varex Imaging Corp.
1678 South Pioneer Road
Salt Lake City, Utah 84104
| Phone | 1-801-972-5000 | Revenue | 844.60M | |
| Industry | Medical Specialties | Net Income | -70,300,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 4.143% | |
| Fiscal Year-end | 09 / 2026 | Employees | 2,400 | |
| View SEC Filings |
VREX Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.585 |
| Price to Book Ratio | 1.053 |
| Price to Cash Flow Ratio | 12.21 |
| Enterprise Value to EBITDA | 8.093 |
| Enterprise Value to Sales | 0.894 |
| Total Debt to Enterprise Value | 0.532 |
VREX Efficiency
| Revenue/Employee | 351,916.667 |
| Income Per Employee | -29,291.667 |
| Receivables Turnover | 5.366 |
| Total Asset Turnover | 0.727 |
VREX Liquidity
| Current Ratio | 3.428 |
| Quick Ratio | 1.829 |
| Cash Ratio | 0.829 |
VREX Profitability
| Gross Margin | 34.395 |
| Operating Margin | 7.826 |
| Pretax Margin | -7.009 |
| Net Margin | -8.323 |
| Return on Assets | -6.049 |
| Return on Equity | -13.953 |
| Return on Total Capital | -8.039 |
| Return on Invested Capital | -7.686 |
VREX Capital Structure
| Total Debt to Total Equity | 85.04 |
| Total Debt to Total Capital | 45.958 |
| Total Debt to Total Assets | 36.292 |
| Long-Term Debt to Equity | 83.707 |
| Long-Term Debt to Total Capital | 45.237 |